![](https://abi.am/wp-content/uploads/Vivan-logo-BLUE-AQUA-LARGE-1.png)
Vivan Therapeutics is a UK-based biotech start-up focused on developing decision platforms for personalized cancer therapeutics. ABI has collaborated with Vivan since 2022, under a service provision agreement. ABI recruited and supervises a team of bioinformaticians and data scientists who get directly involved in the R&D activities of Vivan Therapeutics. The research focuses on genetic biomarker discovery for cancer precision diagnostics & treatment decisions using ML classification & -omics integration in combination with drug screening of genetic flie-models.
People
Supervisor
![](https://abi.am/wp-content/uploads/Hans_klor-3-1-300x300.png)
University of Leipzig
ABI Chairman
ABI Data Scientists
![](https://abi.am/wp-content/uploads/Susanna_Avagyan-01-2-300x300.png)
MSc student
![](https://abi.am/wp-content/uploads/Daniil-Igumnov-1.png)
MSc student